Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JD5W
|
|||
Drug Name |
PMID27998201-Compound-7
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Abdominal aortic aneurysm [ICD-11: BD50.4; ICD-10: I71.3, I71.4] | Patented | [1] | |
Company |
F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H21F2IN4O4S
|
|||
Canonical SMILES |
C1CC1(C#N)NC(=O)C2CC(CN2C(=O)C3(CC3)C4=C(C=C(C=N4)I)F)S(=O)(=O)C5=CC=CC=C5F
|
|||
InChI |
1S/C24H21F2IN4O4S/c25-16-3-1-2-4-19(16)36(34,35)15-10-18(21(32)30-23(13-28)5-6-23)31(12-15)22(33)24(7-8-24)20-17(26)9-14(27)11-29-20/h1-4,9,11,15,18H,5-8,10,12H2,(H,30,32)/t15-,18+/m1/s1
|
|||
InChIKey |
ZEFHIBBPLAGQMT-QAPCUYQASA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathepsin L (CTSL) | Target Info | Inhibitor | [1] |
Cathepsin S (CTSS) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Cathepsin L (CTSL) | Target's Patent Info | [1] | |
Cathepsin S (CTSS) | Target's Patent Info | [1] | ||
KEGG Pathway | Lysosome | |||
Phagosome | ||||
Antigen processing and presentation | ||||
Proteoglycans in cancer | ||||
Rheumatoid arthritis | ||||
Tuberculosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
Reactome | Endosomal/Vacuolar pathway | |||
Collagen degradation | ||||
Degradation of the extracellular matrix | ||||
Trafficking and processing of endosomal TLR | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
MHC class II antigen presentation | ||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | |||
Class I MHC mediated antigen processing & presentation | ||||
Trafficking and processing of endosomal TLR |
References | Top | |||
---|---|---|---|---|
REF 1 | Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.